$1,417.43 USD (+1.84% in 24 hours)
Eli Lilly is a global pharmaceutical company with core franchises in diabetes, obesity, oncology, immunology.
As of 2026-10-31 01:55 UTC. The Crypto App market data.
Eli Lilly is a global pharmaceutical company with core franchises in diabetes, obesity, oncology, immunology, neuroscience and rare diseases. Market attention is centered on its GLP-1/GIP metabolic-drug portfolio, while pipeline progress, manufacturing capacity expansion and pricing/reimbursement policy remain key long-term variables.